| News & Announcements | Laboratory Testing, Vaccination, and Treatment for Monkeypox for Independence Commercial Members | | | | | | 8/24/2022 | | | |
| News & Announcements | Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial Members (Updated August 25, 2022) | | | | | | 8/25/2022 | | | |
| Notifications | Nebulizers and Inhalation Solutions | 05.00.15s | 8/5/2022 9:00 AM | 9/5/2022 | | | 8/5/2022 | Medical Necessity Criteria | | |
| Notifications | Durable Medical Equipment (DME) and Consumable Medical Supplies | 05.00.21z | 8/5/2022 2:00 PM | 9/5/2022 | | | 8/5/2022 | Coverage and/or Reimbursement Position;Medical Coding | | |
| Notifications | Hospital Beds and Accessories | 05.00.56k | 8/12/2022 9:00 AM | 9/12/2022 | | | 8/12/2022 | General Description, Guidelines, or Informational Update | | |
| Notifications | Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®) | 08.01.41d | 8/30/2022 10:00 AM | 11/29/2022 | | | 8/30/2022 | Medical Necessity Criteria | | |
| Updated Policies | Radiologic Guidance and/or Supervision and Interpretation of a Procedure | 00.10.36u | | 8/1/2022 | | | 8/1/2022 | Medical Coding | | |
| Updated Policies | Daratumumab (Darzalex®), Daratumumab, and Hyaluronidase-fihj (Darzalex Faspro®) | 08.01.29j | | 8/15/2022 | | | 8/15/2022 | Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Home Prothrombin Time Monitoring | 05.00.26j | 7/15/2022 9:00 AM | 8/15/2022 | | | 8/15/2022 | Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Wheelchair Cushions and Seating | 05.00.55j | 7/15/2022 9:00 AM | 8/15/2022 | | | 8/15/2022 | General Description, Guidelines, or Informational Update | | |
| Updated Policies | Asparaginase Erwinia Chrysanthemi (Erwinaze®), asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze™) | 08.01.35f | | 8/15/2022 | | | 8/15/2022 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Radiofrequency, Cryosurgical and Microwave Ablation of Lung Tumors | 11.00.16h | | 8/15/2022 | | | 8/15/2022 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Lipectomy and Liposuction | 11.08.03l | | 8/15/2022 | | | 8/15/2022 | Coverage and/or Reimbursement Position;Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Sacituzumab govitecan-hziy (TrodelvyTM) | 08.01.60d | | 8/15/2022 | | | 8/15/2022 | Medical Necessity Criteria | | |
| Updated Policies | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane® for Injectable Suspension) | 08.00.90n | | 8/29/2022 | | | 8/29/2022 | Medical Necessity Criteria | | |
| Updated Policies | Outpatient Physical Medicine, Rehabilitation, and Habilitation Services | 10.03.01n | | 8/29/2022 | | | 8/29/2022 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Home Health Care Services | 02.01.01f | | 8/29/2022 | | | 8/29/2022 | Coverage and/or Reimbursement Position;Medical Coding;General Description, Guidelines, or Informational Update | | |
| Updated Policies | Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation | 11.06.06g | | 8/29/2022 | | | 8/29/2022 | Medical Necessity Criteria;General Description, Guidelines, or Informational Update | | |
| Reissue Policies | Trigger Point Injections | 11.14.02q | | 10/1/2021 | 7/27/2022 | | 8/1/2022 | | | |
| Reissue Policies | Bone Mineral Density (BMD) Testing | 09.00.04l | | 1/1/2022 | 8/10/2022 | | 8/11/2022 | | | |
| Reissue Policies | Screening for Vertebral Fracture with Dual-Energy X-ray Absorptiometry (DEXA/DXA) | 09.00.40d | | 2/18/2016 | 8/10/2022 | | 8/11/2022 | | | |
| Reissue Policies | Moxetumomab Pasudotox-tdfk (Lumoxiti™) | 08.01.53b | | 10/1/2019 | 8/10/2022 | | 8/15/2022 | | | |
| Reissue Policies | Electron Beam Computed Tomography (EBCT) for Screening Evaluations | 09.00.02f | | 8/2/2021 | 8/24/2022 | | 8/25/2022 | | | |
| Reissue Policies | Nonemergent Inpatient Video Electroencephalogram (EEG) Monitoring and Ambulatory EEG Monitoring in the Home | 07.03.25a | | 1/1/2020 | 8/24/2022 | | 8/25/2022 | | | |
| Reissue Policies | Acupuncture (Independence) | 12.00.01g | | 10/1/2021 | 8/24/2022 | | 8/25/2022 | | | |
| Reissue Policies | Endovascular Stent-Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions | 11.02.17g | | 1/1/2022 | 8/24/2022 | | 8/25/2022 | | | |
| Reissue Policies | Erythropoiesis-Stimulating Agents (ESAs) | 08.00.75o | | 9/27/2021 | 8/24/2022 | | 8/26/2022 | | | |
| Reissue Policies | Steroid-Eluting Sinus Stents and Implants | 11.16.08f | | 9/13/2021 | 8/24/2022 | | 8/26/2022 | | | |